NCT06529445

Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 84 (actual)
• Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect and Relative bioavailability of VC004 Capsules in healthy subjects

Conditions

• Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Interventions

Type	Name	Description
DRUG	High Dose VC004 Capsules	VC004 Capsules qd per period, for two periods
DRUG	Median Dose VC004 Capsules	VC004 Capsules qd per period, for two periods
DRUG	Low Dose VC004 Capsules	VC004 Capsules qd per period, for two periods

Timeline

• Start date: 2024-07-22
• Primary completion: 2024-08-26
• Completion: 2024-08-26
• First posted: 2024-07-31
• Last updated: 2024-08-29

Locations

1 site across 1 country: China